NCT05091619: A Phase 3 Study of BIBP Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed
- State
- Under way
- Phase
- Phase 3
- People
- 2,898 taking part
- Started
- 22 Oct 2021
- Primary completion
- 22 Jan 2024
- Arms
- A1, B1, B3, C1, C2, C3
- Results
- None posted
- 22 Oct 2021: Trial started
- 25 Oct 2021: Trial registered